Larson Financial Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Other funds holding RIGL
Larson Financial Group's RIGL Position: Q3 2026 in Review
Larson Financial Group increased its Rigel Pharmaceuticals (RIGL) stake by 25% in Q3 2026, buying an estimated $1.17K and bringing the position to 136 shares worth $6.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2735.
Larson Financial Group first reported a position in RIGL in Q4 2025 and has held it in 4 quarters since. 169 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.
- Larson Financial Group held 136 shares of Rigel Pharmaceuticals worth $6.55K as of Q3 2026.
- Larson Financial Group bought 27 Rigel Pharmaceuticals shares in Q3 2026, an estimated $1.17K.
- Rigel Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2735 holding.
- Larson Financial Group first reported a position in Rigel Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
- 169 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.